Asia Pacific news

Screengrab of Circle DNA's official website.

By Dean Koh February 19, 2019
Beijing-headquartered clinical genomics testing company, Berry Genomics and Hong Kong and London-headquartered genetics and digital health company Prenetics announced today key management hires for the new company, Circle DNA, which will be operational for business by the end of Q2 2019. The 3 key management hires for Circle DNA are Joe Yan (CEO), Claire Wan (COO) and Candy Liu (Head of Marketing...

Above: Screengrab of Burning Rock's website.

By Dean Koh February 14, 2019
Burning Rock Biotech, which was founded in 2014 and focuses on NGS (Next-Generation Sequencing) diagnostics solutions for precision medicine in oncology, today announced the closing of the Series C financing totaling RMB 850 million. The financing was led by GIC, followed by LYFE Capital, CMB International Capital, Lilly Asia Ventures (LAV), Sequoia Capital China and T&Brothers Capital. The...
Millenial on a laptop
By Laura Lovett February 12, 2019
When it comes healthcare, young adults expect more technology and nontraditional settings to be integrated into their care than previous generations, according to a new study released by Accenture at HIMSS19 this morning. The study found that Gen Zers and millennials are much less likely to have a primary care doctor than older generations. In fact, only 67 percent of millennials and 55 percent...

Above image: The Dinsow mini, an elderly care robot made by Thai manufacturer CT Asia Robotics​. Credit: Dinsow Elderly Companion

By Dean Koh February 8, 2019
Under its Thailand 4.0 vision, Thailand plans to leverage on its reputation and excellence in medical services and medical devices and strengthen its position as the regional medical hub. To promote medical robotics, Thailand Board of Investment (BOI) has offered a wide range of investment promotion incentives related to three targeted activities – manufacture of automation machinery/equipment...
By Dean Koh February 7, 2019
Digital therapeutics company Kaia Health has unveiled a feasibility study to examine the impact of its digital therapeutic treatment of Chronic Obstructive Pulmonary Disease (COPD) on Japan’s ageing population. This follows a German pilot study which successfully decreased symptoms. COPD is an umbrella term to describe chronic lung diseases that cause limitations in lung airflow. According to the...

From left to right: (Ying Tang, Vice President, Head of Business Operation, Healthcare, Merck China; Rogier Janssens, Managing Director and General Manager, Biopharma, Merck China; Chris Round, Executive Vice President, Head of International Operation & Global Core Franchise, Healthcare, Merck; Meng Zhang, Vice President, Tencent Medical; Jordan Liu, Strategy and Business Development Director, Tencent Medical)​. Photo credit: Merck

By Dean Koh January 24, 2019
Yesterday, Merck, a German multinational pharmaceutical, chemical and life sciences company, and Tencent, a Chinese multinational investment holding conglomerate, signed a strategic collaboration agreement. The collaboration will primarily focus on increasing public disease awareness and providing more accessible healthcare services via digital platforms in China. “In this collaboration with...

Credit: Ping An Good Doctor

By Dean Koh January 22, 2019
Ping An Good Doctor, a one-stop healthcare ecosystem platform from China, recently announced that their “Voiceprint Login System” (“Voiceprint Lock”), jointly developed with Unisound, an intelligent voice and language technology company in China, has achieved a login success rate close to 99%. The breakthrough came after several model optimisations and upgrades. In December 2017, Ping An Good...

A screengrab of an animated simulation of how AWAK's peritoneal dialysis device works. Credit: AWAK

By Dean Koh January 11, 2019
Earlier this week, AWAK Technologies (AWAK), a Singapore-headquartered medical technology company focused on dialysis using regeneration technology for end-stage renal disease, announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to its AWAK Peritoneal Dialysis (AWAK PD) device, a wearable and ultra-portable PD system that incorporates AWAK’s...

Photo: Dr. James Creeden, Global Medical Director of Foundation Medicine​. Credit: Foundation Medicine.

By Dean Koh January 10, 2019
Launched in 2010 with a $25 million Series A financing led by Third Rock Ventures, Foundation Medicine released its first commercial assay called FoundationOne in 2012. The company develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumours, hematologic malignancies, and sarcomas. In December 2017, the company’s assay FoundationOne...

Editor's Pick